EPISODE · Feb 16, 2021 · 4 MIN
Dr Saad Highlights Results Following the ACIS Study
from Oncology Learning Network · host HMP Global
Fred Saad, MD, University of Montreal Hospital Center, highlights, "Results from ACIS, a Randomized, Placebo Controlled Double-Blind Phase 3 Study of Apalutamide and Abiraterone Acetate Plus Prednisone Versus Abiraterone in Patients with Chemo-Naive Castration-Resistant Prostate Cancer."
Embed this episode
Ready to play
Dr Saad Highlights Results Following the ACIS Study
0:00
4:06
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 4 minutes long.
When was this Oncology Learning Network episode published?
This episode was published on February 16, 2021.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!